| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $68K | +1268.9% |
| Cost of Revenue | $128K | +313.6% |
| Gross Profit | -$60K | -1902.5% |
| R&D Expense | $352K | +8.5% |
| SG&A Expense | $297K | +22.6% |
| Operating Income | -$3.2M | -21.5% |
| Pre-tax Income | -$3.1M | -5.3% |
| Net Income | -$3.1M | -5.3% |
| EPS (Basic) | -$0.01 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $22K | +116.3% |
| Inventory | $57K | — |
| Current Assets | $1.7M | -26.1% |
| Total Assets | $1.9M | -16.4% |
| Current Liabilities | $118K | +36.8% |
| Total Liabilities | $207K | +139.8% |
| Stockholders' Equity | $1.7M | -22.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | -22.2% |
| Capital Expenditures | $103K | — |
| Investing Cash Flow | -$103K | — |
| Financing Cash Flow | $1.5M | -34.6% |
| Free Cash Flow | -$2.2M | — |
| +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |